Lbl12.5mg100.jpg
Carvedilol Tablet, Film Coated
Product Images NDC 68462-162
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 68462-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Lbl3.125mg100.jpg
Lbl6.25mg100.jpg
Carvedilol 25mg 100tab
Figure-1 (Figure 1)
This is a not-available description as the provided text contains only a few numerical characters and medication names without any context or information.*
Figure-2 (Figure 2)
Figure-3 (Figure 3)
The text describes a figure labeled as "Survival Analysis for CAPRICORN (intent-to-treat)." The figure consists of a line graph plotting time (up to 24 units) on the x-axis against the percentage of mortality on the y-axis. There are two lines on the graph: one labeled "Placebo" that begins at 30% mortality and ends at approximately 60% mortality, and one labeled "Carvedilol" that begins at 28% mortality and ends at approximately 45% mortality. The figure also includes labels on the x-axis at 3-month intervals. The P-value for the comparison between the two groups is 0.03.*
Figure-4 (Figure 4)
The text appears to be a table or a figure with subgroups and their corresponding effects on mortality for CAPRICORN. It is not possible to generate a useful description without visual information on the table/figure.*
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
